Essentially, an existing study elucidated the significance of the mitogen-activated protein kinases/extracellular signal-regulated kinase (MEK/ERK) signaling pathway in respect to the therapeutic value of MCM6 in hepatocellular carcinoma [15]. Here, MAP2K7 is linked to hepatocellular carcinoma.